Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease  by Norman, Jason M. et al.
Article
Disease-Specific Alterations in the Enteric Virome in
Inflammatory Bowel DiseaseGraphical AbstractHighlightsd The enteric virome is abnormal in multiple inflammatory
bowel disease patient cohorts
d The enteric virome richness increases in Crohn’s disease
and ulcerative colitis
d Decreases in bacterial diversity and richness in IBD do not
explain virome changes
d Virome changes in Crohn’s disease and ulcerative colitis are
disease specificNorman et al., 2015, Cell 160, 447–460
January 29, 2015 ª2015 Elsevier Inc.
http://dx.doi.org/10.1016/j.cell.2015.01.002Authors
Jason M. Norman, Scott A. Handley, ...,
Miles Parkes, Herbert W. Virgin
Correspondence
virgin@wustl.edu
In Brief
The enteric virome is abnormal in multiple
cohorts of inflammatory bowel disease
patients, exhibiting disease-specific
features that are not explained by
changes in bacterial diversity and
richness.
ArticleDisease-Specific Alterations
in the Enteric Virome
in Inflammatory Bowel Disease
Jason M. Norman,1,10 Scott A. Handley,1,10 Megan T. Baldridge,1 Lindsay Droit,1 Catherine Y. Liu,1 Brian C. Keller,1,2
Amal Kambal,1 Cynthia L. Monaco,1,2 Guoyan Zhao,1,3 Phillip Fleshner,4 Thaddeus S. Stappenbeck,1
Dermot P.B.McGovern,5 Ali Keshavarzian,6 Ece A.Mutlu,6 Jenny Sauk,7 Dirk Gevers,8 Ramnik J. Xavier,7,8 DavidWang,1,3
Miles Parkes,9 and Herbert W. Virgin1,*
1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
2Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
3Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO 63110, USA
4Division of Colorectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
5The F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; Cedars-Sinai Medical Center, Los Angeles,
CA 90048, USA
6Department of Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, IL 60612, USA
7Gastrointestinal Unit andCenter for the Study of Inflammatory Bowel Disease,Massachusetts General Hospital andHarvardMedical School,
Boston, MA 02114, USA
8Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
9Division of Gastroenterology Addenbrooke’s Hospital and Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK
10Co-first author
*Correspondence: virgin@wustl.edu
http://dx.doi.org/10.1016/j.cell.2015.01.002SUMMARY
Decreases in the diversity of enteric bacterial popula-
tions are observed in patients with Crohn’s disease
(CD) and ulcerative colitis (UC). Less is known about
the virome in these diseases. We show that the
enteric virome is abnormal in CD and UC patients.
In-depth analysis of preparations enriched for free
virions in the intestine revealed that CD and UC
were associated with a significant expansion of
Caudovirales bacteriophages. The viromes of CD
and UC patients were disease and cohort specific.
Importantly, it did not appear that expansion and
diversification of the enteric virome was secondary
to changes in bacterial populations. These data sup-
port a model in which changes in the virome may
contribute to intestinal inflammation and bacterial
dysbiosis. We conclude that the virome is a candi-
date for contributing to, or being a biomarker for, hu-
man inflammatory bowel disease and speculate that
the enteric virome may play a role in other diseases.INTRODUCTION
Inflammatory bowel disease (IBD) is a complex, remitting and
relapsing inflammatory disease with genetic and environmental
risk factors. One environmental contributor is thought to be mi-
croorganisms that live in the intestine (Gevers et al., 2014; Kostic
et al., 2014; Minot et al., 2011; Norman et al., 2014; Virgin, 2014).
Of these microorganisms, bacteria have gained the greatestattention and are linked to training mucosal immunity and
minimizing mucosal inflammation (reviewed in Belkaid and
Hand [2014]). An aberration in either of these immune pro-
cesses can have detrimental consequences for IBD progression.
For example, a reduction of Bacteroidetes and Firmicutes and
expansion of normally less abundant bacterial taxa (dysbiosis),
as well as changes in bacterial microbiome function, have
been associated with both Crohn’s disease (CD) and ulcerative
colitis (UC) (Kostic et al., 2014; Stappenbeck et al., 2011). Impor-
tantly, household contacts without IBD can also exhibit signs of
bacterial dysbiosis (Joossens et al., 2011). These individuals
have increased intestinal permeability compared to healthy com-
munity controls (Hollander et al., 1986), suggesting that the bac-
terial microbiome is heavily influenced by the household environ-
ment. Investigations have also shown that the home environment
is a primary determinant of the individual’s bacterial microbiome
and that humans are the primary vector of bacterial transmission
between people living within the same household (Lax et al.,
2014). Exchange of viruses between humans within a household
has not been thoroughly investigated. Nevertheless, investiga-
tions of the bacterial microbiome and the enteric virome in IBD
are likely to be optimized by the investigation of household con-
trols rather than matched controls from different households.
Emerging data indicate that the viral component of the micro-
biome, termed the virome, can profoundly influence host physi-
ology (Handley et al., 2012; Norman et al., 2014; Virgin, 2014).
Recent advances in sequencing technology have led to the dis-
covery of a diverse enteric human virome consisting of bacterio-
phages, as well as eukaryotic viruses (Breitbart et al., 2003; Fink-
beiner et al., 2008; Minot et al., 2011, 2012, 2013; Reyes et al.,
2010). Importantly, evidence that eukaryotic viruses can interact
with IBD risk genes to alter intestinal disease comes from studiesCell 160, 447–460, January 29, 2015 ª2015 Elsevier Inc. 447
of mice carrying mutations in Il-10 or Atg16l1, indicating that
members of the virome may contribute to IBD (Basic et al.,
2014; Cadwell et al., 2010; Irving and Gibson, 2008; Sun et al.,
2011). Bacteriophages may also play a direct role in intestinal
physiology or change the bacterial microbiome through pred-
ator-prey relationships (Barr et al., 2013; Duerkop et al., 2012;
Reyes et al., 2013; Willner et al., 2009, 2012).
The virome, much of which is composed of bacteriophages,
contains the most diverse genetic elements on earth and is
only beginning to be characterized at the sequence level (Virgin,
2014). In the absence of disease, enteric bacteriophage popula-
tions exhibit significant diversity between individuals and are
temporally stable (Minot et al., 2013; Reyes et al., 2010). Bacte-
riophages in the healthy human intestine are predominantly
temperate double-stranded DNA (dsDNA) Caudovirales or sin-
gle-stranded DNA (ssDNA) Microviridae that latently infect their
bacterial hosts and generate few viral progeny that may infect
and kill other bacteria (Minot et al., 2011, 2013; Minot et al.,
2011; Reyes et al., 2010; Waller et al., 2014). However, environ-
mental stimuli, such as nitric oxide and antibiotics, induce the
production of infectious bacteriophages that lyse their bacterial
host and infect neighboring cells bearing specific receptors
(Lindsay et al., 1998; Maiques et al., 2006; Zhang et al., 2000;
Zhang and LeJeune, 2008). This process releases infectious vi-
rions into the intestine, which can be purified and analyzed. Alter-
ations in bacteriophage abundance have been suggested in CD
(Lepage et al., 2008; Pe´rez-Brocal et al., 2013; Wagner et al.,
2013); however, these studies did not characterize the enteric vi-
rome in detail and did not control for factors within households
that may influence the microbiome.
Here, we characterized the normal human and IBD enteric
virome by metagenomic sequencing of the DNA of virus-like
particle (VLP) preparations from fecal samples obtained from
UC and CD patients and controls. Throughout the text, we refer
to two ecological metrics, richness (the number of taxa counted
per sample) and diversity. Diversity measures both richness
and the relative abundance (or evenness) of the taxa present;
changes in diversity can result from alterations in either richness
or evenness. Detailed analysis of purified virions in VLP prepara-
tions and bacterial 16S ribosomal RNA sequences from a longi-
tudinal patient cohort compared to household controls revealed
the expected decrease in bacterial richness and diversity
accompanied by a striking IBD-associated increase in bacterio-
phage richness. These findings were validated in two indepen-
dent and geographically distinct patient cohorts that contained
matched controls. The taxonomic substructure of the enteric
virome and bacterial microbiome in CD and UC showed
geographic variation in the specific bacteria and viruses
detected. Together, these data support a model in which IBD-
associated increases in bacteriophage richness are not merely
accounted for by an increase in their bacterial host cells. We
observed both positive and negative correlations between spe-
cific viral and bacterial taxa. These data demonstrate, for the first
time, that unique changes in the bacteriophage component of
the enteric virome occur in CD and UC, raising the possibility
that these changes may contribute to disease pathogenesis,
perhaps through a predator-prey relationship between bacterio-
phages and their bacterial hosts. These data provide a rationale448 Cell 160, 447–460, January 29, 2015 ª2015 Elsevier Inc.for considering virome diagnostics for IBD and manipulation of
the enteric virome as a novel therapeutic strategy for the man-
agement of IBD and emphasize the need for a greater under-
standing of transkingdom interactions within the microbiome
for other diseases associated with changes in the bacterial
microbiome (Duerkop and Hooper, 2013; Norman et al., 2014;
Virgin, 2014).
RESULTS
Virome Alterations Are Observed in Multiple Cohorts
To initially define the enteric virome associated with IBD, we
performed metagenomic sequencing of stool filtrates using the
Roche 454 platform on three independent cohorts consisting
of IBD and non-IBD household controls (Tables S1 and S2;
Cambridge, United Kingdom; Chicago, USA; and Los Angeles,
USA). On average, we obtained 32,591 ± 27,531 sequences
(number ± SD) that were 282 ± 47 nucleotides in length from
72 fecal samples (Table S3; 12 household controls, 18 CD, and
42 UC). Sequences were demultiplexed, quality filtered, and as-
signed taxonomy (Supplemental Information). The majority of
sequences obtained were assigned to the human host or to bac-
terial taxa (Table S3). Consistent with previous reports, bacterio-
phages of the Caudovirales order and Microviridae family were
the most abundant viral taxa identified in all three cohorts (Fig-
ure 1A) (Minot et al., 2011; Reyes et al., 2010). Other viruses
were detected in a limited number of samples and represented
an average of five percent or fewer of the total viral sequences.
An analysis of the relative abundances of sequences from
all three cohorts revealed an inverse correlation between the
Caudovirales and Microviridae (Figure 1B). This inverse correla-
tion was also present when controls, CD, and UC were analyzed
separately (data not shown). Comparing household controls to
IBD samples within the UK cohort revealed that this dispropor-
tionate representation of bacteriophage abundance was associ-
ated with IBD (Figure 1C). Disparate ratios of Caudovirales and
Microviridae were also observed in patients from Los Angeles.
This suggestive correlation between disease and a change
in sequences from the enteric virome was striking given the
geographical and environmental diversity of the cohorts.
In-Depth Analysis of Free Virions in the Enteric Virome
in IBD
These initial observations prompted us to perform an in-depth
analysis of the virome by metagenomic sequencing of VLPs
purified from the feces of patients and controls from 17 IBD
households in the UK (Figure 2A and Tables S1 and S2). VLP pu-
rification enriches for free virions (Reyes et al., 2012; Thurber
et al., 2009). To further refine the relationship between IBD and
the enteric virome and to take into account prior data indicating
that the bacterial microbiome and virome are similar within
households (Lax et al., 2014; Reyes et al., 2010), we compared
IBD patients to matched household controls (Figure 2A). This is
particularly important for virome analysis given the high interper-
sonal variation of viruses (Reyes et al., 2010). Samples were
collected from both the IBD patient and household control at
the time of a clinical flare of disease (Supplemental Information).
In total, 21 household control samples and 52 IBD samples
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Figure 1. Virus Taxonomic Assignment and
Imbalance in IBD
(A) Relative abundance of sequences assigned to
the indicated viral taxa. Error bars represent the
mean ± SD.
(B) Correlation plot of the Caudovirales and
Microviridae relative abundance for all samples.
Linear regression ± 95% confidence interval and
Spearman correlation coefficient are shown.
(C) Microviridae and Caudovirales relative abun-
dance for United Kingdom household controls,
UC and CD (top); Los Angeles and Chicago IBD
(bottom). The bars indicate the median and inter-
quartile range. Statistical significance was deter-
mined by the Mann-Whitney test.
See also Tables S1, S2, and S3.(24 active disease and 28 inactive disease samples; 36 total UC
and 16 total CD) were used to isolate VLPs for sequencing. We
validated observations in two additional cohorts from Chicago
and Boston that contained CD and UC patients and matched
healthy control subjects (described in greater detail below;
Tables S1 and S2).
For the UK cohort, we obtained 1,111,569 ± 493,164 paired-
end sequences per sample with an average sequence quality
of 36.5 ± 3.7 (Table S4 and Experimental Procedures). Quality
control trimming resulted in an average of 2% reduction in the
number of sequences to 1,094,360 ± 503,337 with an average
reduction in sequence length from 250 to 241.7 ± 3.7 bases
and an average increase in quality score of 1.0 ± 0.03. There
were no statistically significant differences in the number of total
or quality-controlled sequences obtained between control and
IBD patient samples (Figure S1A). Sequences were clustered
at 95% identity to remove similar sequences and to generate
sequences termed unique hereafter. Clustering resulted in an
average reduction of 89% to112,192±71,820 unique sequences
per sample. Interestingly, despite the fact that there were no sig-
nificant differences in the total sequences obtained, we detected
a significant increase in unique reads in CD patients compared to
either household controls or UC patients. (Figure S1A).
Increased Caudovirales Taxonomic Richness
Associated with IBD
Unique sequences were mapped to a custom virus protein data-
base, as described in the Experimental Procedures. We wereCell 160, 447–460able to assign viral taxonomy to an
average of 17,022 ± 15,725 sequences
(15%) (Figure S1A), with the majority
belonging to Caudovirales and Micro-
viridae bacteriophages (Figure S1B).
Sequences were also assigned to
many less-abundant viral taxa, including
bacteriophages whose annotated hosts
include bacteria commonly found in hu-
man fecal samples and common eukary-
otic viruses (Figure S1B). Analysis of our
VLP sequences revealed a low level of
contamination with human sequences(0%– 4%). Possible contamination with bacterial sequences
was confounded by the presence of integrated prophages in
full genome sequences of bacteria. We mapped a subset of
our total VLP enriched sequences from the UK cohort to the
recently discovered crAssphage genome and detected it in
71% of our samples (Dutilh et al., 2014) (Table S4). The percent-
age of sequences that mapped to this virus varied greatly (range
1%–89%) and did not correlate with disease status or drug
treatment.
Interestingly, we observed an increase in the richness of bac-
teriophages, specifically, members of the Caudovirales in IBD
(Figures 3A and 3B). It is unlikely that these differences can be
attributed to an uneven number of samples or unique sequences
in control and disease groups because the rate of acquisition of
new bacteriophage taxa in disease samples rapidly outpaces
new taxa acquisition in control samples (Figure 3B). No in-
creases inMicroviridae richness or diversity were observed (Fig-
ure S2A), indicating that bacteriophage expansion was restricted
to certain taxa and that our methods do not systematically in-
crease bacteriophage richness in IBD samples compared to
controls. Some IBD samples had many fewer Microviridae than
controls, further supporting that the viromes were different be-
tween the two disease states (Figure S2A).
Taxonomic assignment of de novo assembled contigs longer
than 1,000 nucleotides also indicated thatCaudoviraleswere en-
riched in IBD (Figure 3C). These data indicated that the VLP
preparations contained partial or complete virus genomes and
that the overwhelming majority of those assignable genomes, January 29, 2015 ª2015 Elsevier Inc. 449
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Figure 2. In-Depth, Longitudinal Cohort Graphical Timeline
(A) United Kingdom IBD stool samples and non-IBD household control stools were collected at the onset of symptoms (flare) and collected as symptoms resolved
where indicated. The length of each IBD flare is indicated by the red shaded oval. The samples are annotated by household ID and sample number.
(B) Chicago UC samples were collected first during inactive disease and again when symptoms exacerbated. The samples are annotated by the subject and
sample number.
See also Tables S1 and S2.were from Caudovirales bacteriophages. Taken together, Cau-
dovirales sequences and assembled contigs were differentially
expanded in CD and UC compared to household controls and
were therefore capable of having disparate effects on the micro-
biome and immune responses.
Disease-Specific Changes in the Enteric Virome
In addition to differences in bacteriophage richness between
IBD and household control samples, we also observed striking
differences in richness and the types of bacteriophage taxa
observed between CD and UC samples (Figure 3D). A substan-
tial number of taxa were observed among all samples; however,
each disease type harbored unique bacteriophages. These450 Cell 160, 447–460, January 29, 2015 ª2015 Elsevier Inc.differences in Caudovirales taxa could be the result of multiple
factors, including health or disease, household, duration of
cohabitation, disease activity, age, sex, and/or drug treatment.
We therefore performed a multivariate analysis of Caudovirales
abundance using MaAsLin (Multivariate Association with Linear
Models) on VLP sequences compared to their household
controls (Morgan et al., 2012). MaAsLin identified 35 different
Caudovirales that were significantly associated with different
households (43 total associations) (Tables S5 and S6). This rela-
tionship was also revealed by plotting Caudovirales relative
abundances, which indicate conservation within households
(Figure 3E). This finding is consistent with a previous report
(Reyes et al., 2010). Five of the Caudovirales identified by
A B
C
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E
Figure 3. Bacteriophage Expansion Is Associated with CD and UC
(A) Presence-absence heat map of the sequences assigned to Caudovirales taxa in VLP preparations from UK household control, CD and UC stool samples.
(B and C) Rarefaction curves of Caudovirales richness versus an increasing number of subsamplings with replacement.
(B) Caudovirales richness based on individual sequences.
(C) Richness based on assembled Caudovirales contigs. The curves represent the average of 500 iterations at each depth of samples.
(D) Venn diagram of the Caudovirales taxa in household control, CD and UC samples. n indicates the number of samples within each subgroup.
(E and F) Plots of the relative abundance of the 35 most abundant Caudovirales taxa in the UK UC and CD households. Bars are annotated by the household ID
and sample number. Green numbers indicate household controls; purple numbers indicate CD; red numbers indicate UC.
See also Figure S1 and Tables S4, S5, and S6.
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MaAsLin were significantly associated with disease, including
sequences most closely related to Lactococcus, Lactobacillus,
Clostridium, Enterococcus, and Streptococcus bacteriophages
(Table S6). The increased Caudovirales richness in CD samples
relative to household controls corresponded with increased
bacteriophage diversity (Figure S2B). This was not observed
in UC, further highlighting differences in the virome between
UC and CD.
Inverse Correlation between IBD-Associated Changes
in the Virome and Bacterial Microbiome
We next assessed whether the increase in bacteriophage rich-
ness observed in CD and UC was associated with a parallel
change in bacterial populations. To answer this question, we
performed bacterial 16S rRNA gene sequencing (Tables S1
and S2). On average, we obtained 64,107 ± 38,570 sequences
that were clustered at 97% identity into 56,096 ± 32,774
operational taxonomic units (OTUs) per sample (Table S7). As
expected, CD and UC were associated with a significant reduc-
tion in bacterial diversity and bacterial richness compared to
household controls (Figures 4A and 4B). However, we also
observed significant similarity in the bacterial microbiome
within IBD households as determined by permutation multivar-
iate analysis of variance of the weighted UniFrac distances
(Figures 4B and 4C; ADONIS p = 0.001, 999 permutations)
(McArdle and Anderson, 2001). Interestingly, in patients that
were sampled longitudinally, the bacterial diversity did not
recover during periods of disease inactivity in either CD or UC
(Figures 4B and 4C).
Like the shifts observed for bacteriophages, the changes in
bacterial diversity could be multifactorial. We therefore per-
formed a multivariate analysis of bacterial abundance using
MaAsLin (Morgan et al., 2012). We identified 18 different
bacterial taxa that were significantly associated with disease or
disease activity (Tables S5 and S8). The vast majority of the sig-
nificant OTUs were of the Bacteriodetes and Firmicutes phyla,
including significant differences inmembers of the bacterial fam-
ilies Ruminococcaceae, Lachnospiraceae, Bacteriodaceae, and
Prevotellaceae. Therefore, and as expected, disease-specific
alterations in bacterial taxa were observed in our cohort; how-
ever, the variation was also largely linked to specific households,
supporting previous studies of the microbiome that have indi-
cated similarities among IBD patients and their household
contacts (Joossens et al., 2011).
Importantly, the observed reduction in bacterial diversity was
inversely related to the expansion of Caudovirales bacterio-
phages in IBD. Comparing the bacterial and Caudovirales
bacteriophage communities in household controls, CD and UC
samples indicated clear differences between the disease states
(Figure 5A). Among the UK cohort, significant positive correla-Figure 4. Alterations in the Bacterial Community Composition in IBD
(A) Alpha diversity (left) and bacterial species richness (right) based on 16S rRNA
bars indicate the mean ± SD. Statistical significance was determined by the Kru
**p > 0.01.
(B and C) Plots of alpha diversity normalized to the diversity in household controls
and (C) UC households. Green numbers indicate household controls; purple num
See also Tables S5, S7, and S8.tions were observed in five out of six possible comparisons
between bacterial diversity or richness and Caudovirales rich-
ness or diversity. However, a significant inverse correlation
was observed in CD samples between Caudovirales diversity
and both bacterial richness and diversity, which suggests that
bacteriophage expansion was not simply the result of increases
in their bacterial hosts (Figure 5A).
To further characterize the relationships between Caudovir-
ales and bacterial taxa, we calculated the Spearman correlation
between the Caudovirales taxa and the bacterial families found
to be significantly altered in disease byMaAsLin analysis. Similar
to the overall diversity and richness correlations, inverse correla-
tions between Caudovirales and the significantly altered bacte-
rial taxa are prevalent in UK CD patients (Figure 5B). In particular,
the Bacteroidaceae bacterial families were inversely correlated
with several Caudovirales taxa in CD. This corresponded with
a reduction in the relative abundance of these bacterial taxa
in CD patients compared to household controls. In contrast,
the Caudovirales were positively correlated with the Enterobac-
teriaceae and Pasteurellaceae bacterial families in CD; these
bacterial families were increased in abundance in CD patients
(Figure 5B). Positive correlations were also observed between
the Caudovirales and Prevotellaceae in CD; however, there
were no changes in the relative abundance of Prevotellaceae in
CD, further indicating that we were not merely sequencing pro-
phages. Fewer positive or negative correlations were observed
in UC patients despite the significant expansion of Caudovirales
bacteriophages and decreased bacterial diversity in these pa-
tients (Figures 3B and 4A), further suggesting the existence of
disease-specific elements of the virome-bacterial microbiome
relationship in UC versus CD.
Independent IBD Cohorts for Validation of Virome
Findings
We considered the possibility that our observations in UK IBD
patients were either geographically determined or not reproduc-
ible. Therefore, we performed bacterial 16S and VLP sequencing
of stool samples from two additional cohorts of CD and UC pa-
tients (Figure 2 and Tables S1 and S2). In these cases, household
controls were not available, and so matched healthy controls
were used. The first validation cohort was from Chicago and
included 23 healthy control samples and 25 IBD samples
(18 UC and 7 CD), including several samples that were part of
the initial 454 analyses (Figure 1). For five of the Chicago UC
patients, we were able to acquire samples both during inactive
and active disease (Figure 2B). Two household controls that
matched UC patients from Chicago were included in these ana-
lyses as healthy subjects. The second validation cohort was from
Boston and included 10 healthy control samples and 25 IBD
samples (11 UC and 14 CD).gene sequences in the stool of household controls, CD, and UC patients. Error
skal-Wallis test with Dunn’s correction comparing all samples to all samples.
(top) and relative bacterial family abundance (bottom) of UK (B) CD households
bers indicate CD; red numbers indicate UC.
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A B
Figure 5. Disease-Specific Bacteria-Caudovirales Patterns in IBD
(A) Spearman correlation plot of Caudovirales richness, Caudovirales Shannon diversity, bacterial alpha diversity, and bacterial species richness for UK
household control, CD, and UC samples. Statistical significance was determined for all pairwise comparisons; those with p values < 0.05 are indicated. Positive
values (blue circles) indicate positive correlations, and negative values (red circles) indicate inverse correlations. The size and shading of the circle indicate the
magnitude of the correlation where darker shades are more correlated than lighter shades.
(B) Spearman correlation plots of the relative abundances of the 50 most abundant Caudovirales taxa and bacterial families identified to be significantly
associated with disease. UK household control (top), CD (middle), and UC (bottom) samples. The gray bars indicate any taxa that were not detected in the cohort
subgroup. Statistical significance was determined for all pairwise comparisons; only significant correlations (p value < 0.05) are displayed.
See also Figure S2.Relationship between Caudovirales Richness and IBD
across Cohorts
Asexpected, significant reductions in bacterial diversity and rich-
ness were observed in CD and UC patients compared to healthy
controls from both the Chicago and Boston validation cohorts
(Figures 6A–6C). MaAsLin analysis of bacterial taxa revealed
significant associations with IBD and disease activity in both Chi-
cago and Boston cohorts, although many fewer bacterial taxa
were significantly associated with IBD than observed in the UK
cohort, which included household controls (Tables S5 and S8).
As observed in the UK cohort (Figure 3), a significant expan-
sion of Caudovirales bacteriophages was observed in IBD
patients from both validation cohorts (Figure 7). However, the
specific relationships between bacteriophage richness and dis-
ease varied between cohorts. In Chicago, CD patients wereCau-
dovirales rich compared to healthy controls (Figures 7A and 7B).
This was evident when richness was assessed for both individual
sequences and Caudovirales contigs. In the Boston cohort, both
CD and UC patients had increased Caudovirales, with UC con-
tigs being more enriched than CD (Figures 7A and 7B). We
also detected unique Caudovirales taxa in CD and UC samples454 Cell 160, 447–460, January 29, 2015 ª2015 Elsevier Inc.from both the Chicago and Boston cohorts (Figure 7C), which
was anticipated given our observations in the UK samples and
the high inter-individual virome diversity reported previously
(Reyes et al., 2010). Multivariate analysis of the relative abun-
dance of Caudovirales in the Chicago and Boston samples
revealed several disease-specific associations (Tables S5 and
S6). We were unable to complete a correlation analysis to asso-
ciate bacteriophage to bacteria abundances (as in Figure 5) due
to the inadequate number of bacterial taxa associated with dis-
ease diagnosis as determined by MaAsLin analysis (Table S8).
Therefore, we were unable to validate specific relationships be-
tween bacteriophage and bacterial taxa across our cohorts.
Together, these data indicate that Caudovirales bacteriophages
were expanded in both CD and UC patients compared to house-
hold or healthy controls from three independent cohorts.
Eukaryotic Viruses in IBD Cohorts
We also took advantage of the available data from the three IBD
cohorts to analyze sequences from eukaryotic viruses. Anellovi-
rus sequences were more prevalent in IBD samples compared
to healthy controls (Table S4; anellovirus positive: household
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Figure 6. Validation of Bacterial Dysbiosis in Two Additional Cohorts
(A and B) Faith’s phylogenetic alpha diversity (left) and bacterial species richness (right) based on 16S rRNA gene sequences in the stool of (A) Chicago healthy
controls, CD, and UC patients and (B) Boston healthy controls, CD, and UC patients. Error bars indicate the mean ± SD. Statistical significance was determined
by the Kruskal-Wallis test with Dunn’s correction comparing all samples to all samples. *p > 0.05 and **p > 0.01.
(C) Plot of alpha diversity normalized to the average diversity in healthy subjects (top) and relative bacterial family abundance (bottom) for the Chicago and Boston
cohorts. Healthy control, UC, and CD samples are indicated. Longitudinal samples from the same subject are grouped together.
See also Tables S5, S7, and S8.controls, 0%; healthy controls, 4.7%; CD, 27%; UC, 29%). How-
ever, anellovirus sequences from fecal samples were not de-
tected in all patients and did not correlate with disease activity
or drug treatment.
DISCUSSION
In this paper, we demonstrate that disease-specific changes in
the enteric virome occur in both major forms of IBD, Crohn’s dis-ease, and ulcerative colitis. This was observed in a cohort of pa-
tients in comparison to household controls with increased power
to detect disease-associated changes in the metagenome and
validated in two independent and geographically distinct cohorts
containing matched controls. The primary change in the virome
associated with IBD was a significant expansion of the taxo-
nomic richness of Caudovirales bacteriophages. Importantly,
although this change was observed in both CD and UC, the vi-
ruses responsible for the change appeared to differ betweenCell 160, 447–460, January 29, 2015 ª2015 Elsevier Inc. 455
A B C
Figure 7. Validation of Caudovirales Expansion in Two Additional Clinical Cohorts
(A and B) Rarefaction curves of Caudovirales richness versus an increasing number of subsamplings with replacement for the Chicago (top) and Boston (bottom)
cohorts.
(A) Caudovirales richness based on individual sequences.
(B) Richness based on Caudovirales contigs.
(C) Venn diagram of the Caudovirales taxa in healthy control, CD, and UC samples from Chicago (top) and Boston (bottom). n indicates the number of samples
within each subgroup.
See also Tables S4, S5, and S6.the two diseases, suggesting that the virome is specific for CD
versus UC. Comparison across cohorts revealed that enteric vi-
romes were unique between individuals and between cohorts,
which is consistent with previous reports on the incredible diver-
sity of the human gut virome (Minot et al., 2011; Reyes et al.,
2010). Although the variability of gut bacteria and viruses in non-
household controls and IBD patients makes it more difficult
to observe specific relationships between individual bacterio-
phages and individual bacterial taxa, an increase in bacterio-
phage richness was consistently associated with IBD despite a
decrease in bacterial richness and diversity.
Our data are consistent with reports that detected more
Caudovirales bacteriophage sequences in intestinal washes
and biopsy tissues of pediatric CD patients compared to nonin-
flammatory controls (Wagner et al., 2013) and enumerated more
Caudovirales virions in CD biopsy washes by microscopy (Lep-
age et al., 2008). We believe that our observations reflect an
expansion of infectious bacteriophages in IBD for two reasons.
First, we sequenced VLP preparations enriched for virions. Sec-
ond, an expansion of temperate bacteriophages integrated in
bacterial genomes would be predicted to positively correlate
with their bacterial hosts while we observe an inverse correlation.
However, our data do not rule out the possibility that bacterial
species harboring specific prophages are also expanded. Anal-
ysis of this will require full sequencing of the bacterial micro-
biome to complement analysis of bacterial taxa via analysis of
16S ribosomal RNA sequences.
Potential Role of Bacteriophages in IBD
In the human gut and in many ecosystems, the predominant
bacteriophages are tailed, dsDNA Caudovirales and non-tailed,456 Cell 160, 447–460, January 29, 2015 ª2015 Elsevier Inc.ssDNA Microviridae (Breitbart et al., 2003; Reyes et al., 2010).
The biology of bacteriophages has been extensively reviewed
(Bru¨ssow et al., 2004; Clokie et al., 2011; Fortier and Sekulovic,
2013). The expansion in Caudovirales bacteriophage richness
observed here could arise from the induction of prophage from
commensal microbes or reflect the introduction of new viruses
acquired from the environment, for example from food or contact
with other people, including household contacts. These changes
might have significant consequences for the bacterial micro-
biome. For example, bacteriophages are primary drivers of bac-
terial diversity and fitness in different ecosystems (Bru¨ssow et al.,
2004). In the gut, bacteriophages are responsible for the horizon-
tal transfer of genetic material among bacterial communities,
including those for pathogenesis (e.g., cholera toxin, pertussis
toxin, and shiga toxin) and antibiotic resistance (Bru¨ssow et al.,
2004; Maiques et al., 2006; Zhang and LeJeune, 2008). Wide-
spread bacteriophage induction, mutation, or introduction from
external sources could effectively shuffle the deck of bacterial
fitnessand resistancegenes.Second, theactivationof latent pro-
phages leads to the lysis of their bacterial hosts andcanhavepro-
found ecological consequences (Weitz and Wilhelm, 2012). The
intestinalmicrobiomehasbeenshown tobesensitive tobacterio-
phage invasion, leading to changes in the abundance of specific
gut bacterial species (Reyes et al., 2013). Lysis of bacteria would
also be expected to release proteins, lipids, and nucleic acids
that serve as pathogen-associated molecular patterns (PAMPs)
and antigens that trigger inflammatory signaling cascades
to induce cytokines, cellular infiltration, and tissue damage. The
development of animal models to test these predator-prey rela-
tionship(s) in IBD pathogenesis and intestinal inflammation will
certainly be an important area for future investigation.
Another potential consequence of a change in enteric bacte-
riophages might result from direct interactions between these vi-
ruses and the mammalian host. For example, bacteriophages
are able to translocate from the gastrointestinal (GI) lumen to
systemic sites in animals (Go´rski et al., 2006), CD patients, and
healthy controls (Parent and Wilson, 1971). Bacteriophages are
also capable of inducing humoral immune responses (Uhr
et al., 1962). Further, in vitro stimulation of macrophages with
bacteriophage particles induces MyD88-dependent proinflam-
matory cytokine production (Eriksson et al., 2009). Chronic intes-
tinal inflammation is the most basic element of IBD pathology,
leading to the destruction of intestinal tissue and increased
epithelial permeability. This leads to increased systemic expo-
sure to the flow of microbial immunogens, potentially including
those from bacteriophages and lysed bacterial cells, to maintain
and further exacerbate inflammation. For these reasons, bacte-
riophages may serve as antigens or innate immune ligands that
stimulate host immunity and inflammation.
The ‘‘Dark Matter’’ of the Virome
The metagenomic sequencing of samples enriched for intact vi-
rions has led to an appreciation of the incredible richness of
enteric viruses in humans. Importantly, the methods we used
here would not be expected to detect either enveloped viruses
or RNA viruses and so there may be much to learn about these
aspects of the IBD virome. Prior attempts to characterize the vi-
rome using these methods were only able to assign 60% to
87% of VLP sequences or contigs to anything within sequence
databases (Minot et al., 2011, 2013). Across our cohorts, we
were only able to assign on average 14% of VLP sequences
to a viral database. The apparent discrepancy between our
study and previous ones may be explained by our use of higher
throughput Illumina-based sequencing, sequence databases,
or taxonomic assignment criteria. The percent identity of those
VLP sequences that were assigned in this study varied greatly in
a subset of sequences that were analyzed (40% to 100% iden-
tity; data not shown). This is a major issue for future studies, as
we were only able to report on the bacteriophages that are most
closely related to taxa in the database. It is likely that additional
viruses are present in our sequencing data sets but are not de-
tected due to this limitation. An implication of this is that current
databases lack sufficient depth for us to be able to link specific
bacteriophages to individual bacteria or disease. This limitation
will only be overcome by significant expansion of the bacterio-
phage sequences and annotations in available databases. This
will not be a simple task and will require a global, coordinated
effort to improve virus databases; it is clear that the Human
Microbiome Project (http://www.hmpdacc.org/), an effort of
similar scale, has improved the ability to classify and study bac-
teria. As databases improve, the resolution of our picture of
bacterial microbiome-virome associations will improve. Many
of the sequences that we did not assign using our viral database
map to bacterial genomes (data not shown), an assignment
complicated by the fact that many bacterial genome sequences
contain prophages that have not been independently anno-
tated. Addressing the misannotation of integrated prophages
as ‘‘bacterial’’ sequences will require development of new tools
and significant improvement of viral databases containinga much greater diversity of fully annotated complete viral
genomes.
Virome Implications for Disease Pathogenesis,
Treatment, and Monitoring
The primary therapeutic goal in IBD is to limit inflammation and
halt or even reverse tissue destruction. In many cases, pharma-
cologic or biomolecule therapies fail, and surgical resection of in-
flamed/damaged tissue is required. Thus, novel approaches are
required to optimize IBD management. One potential approach
is the manipulation of enteric bacteria through probiotics and
prebiotics, which have had limited success in humans thus far
(Butterworth et al., 2008; Naidoo et al., 2011; Shanahan and
Quigley, 2014). Fecal transplantation from healthy donors or
with defined bacterial cultures is an approach that is gaining
traction due to its success in the treatment of recurring Clos-
tridium difficile infections (van Nood et al., 2013). However, early
attempts at curing bacterial dysbiosis in UC through fecal trans-
plantation have not proven successful (Angelberger et al., 2013;
Kump et al., 2013), perhaps due to the instability of the donor
microbiome in IBD patients. It is intriguing to speculate that a dis-
ease-associated, taxonomically rich virome in the recipient may
interact with donor microbes to limit probiotic or fecal transplan-
tation efficacy. Defining the virome before and during probiotic
or fecal transplantation will be required to assess this possibility.
It is notable that, in animal models, eukaryotic viruses change
intestinal biology and inflammation by acting in concert with
host bacteria in a manner dependent on host genetics (Basic
et al., 2014; Cadwell et al., 2010). Thus both eukaryotic viruses
and bacteriophages may have a role in IBD through interactions
with the bacterial microbiome. It will be important to more
completely understand the interactions between bacteria and
viruses and viruses and the host to be able to develop and
personalize these approaches to managing IBD.
Our data also suggest that the specific expansion of bacterio-
phages in CD is associated with decreased bacterial diversity.
The development of methods that block the infection of their
bacterial hosts by these bacteriophages is worth investigation.
Furthermore, the identification of disease-specific Caudovirales
could prove useful in differentiating CD and UC in the 10% of
cases of IBD in which the clinical phenotype is indeterminate be-
tween the two. Here, we did not observe any significant changes
in the virome in IBD patients over time as disease activity
changed. However, larger cohorts with more frequent repeated
sampling of both IBD patients and household controls are
required to more fully assess enteric virome stability in IBD.
Although IBD is associated with bacterial dysbiosis, addi-
tional—and much more common—diseases are also associated
with changes in the bacterial microbiome. These include dia-
betes, obesity, metabolic diseases, and cancer (Larsen et al.,
2010; Ley et al., 2005; Nicholson et al., 2012; Qin et al., 2012;
Shen et al., 2010; Turnbaugh et al., 2006, 2009; Zackular et al.,
2013). Our data indicate that understanding the bacterial micro-
biome in these diseases likely requires concurrent analysis of the
virome. More speculatively, we question whether bacterial mi-
crobiome changes in many diseases are secondary to changes
in emergence of temperate bacteriophages or introduction of
bacteriophages from food, the environment, or through humanCell 160, 447–460, January 29, 2015 ª2015 Elsevier Inc. 457
or animal contact. Thus, data presented here identifying inverse
relationships between the bacterial microbiome and the enteric
virome open up a new area of research in IBD and perhaps other
diseases that have been shown to be associated with changes in
the bacterial microbiome.
EXPERIMENTAL PROCEDURES
Cohort Description
Stool samples were collected at four gastroenterology clinics: (1) Adden-
brooke’s Hospital, University of Cambridge, UK; (2) Cedars-Sinai Hospital,
Los Angeles, USA; (3) Rush University Medical Center, Chicago, USA; and
(4) Massachusetts General Hospital, Boston, USA. A detailed list of the sub-
jects and a full description of each cohort are included in the Supplemental
Information.
Virus-like Particle Enrichment and Sequencing
Virus-like Particle Preparation
VLPs were enriched from pulverized human stool using a protocol based on
previously described methods (Reyes et al., 2010; Thurber et al., 2009). Stool
sample filtrates were treated with lysozyme and chloroform to degrade any
unfiltered bacterial and host cell membranes. Nonvirus protected DNA was
degraded by treating with a DNase cocktail followed by heat inactivation of
DNases. VLPs were lysed and nucleic acid was extracted.
VLP DNAwas amplified, and DNAwas randomly fragmented by ultrasonica-
tion before Illumina library construction. An equimolar pool of 12 samples was
sequenced on an Illumina MiSeq instrument.
Sequence Processing and Analysis
Adapters and low-quality bases were trimmed, and reads were clustered at
95% identity. Unique sequenceswere queried against a customized viral data-
base using BLASTx. Reads were assigned taxonomy using the lowest-com-
mon ancestor algorithm as implemented in MEGAN (v5.1.5) (Huson et al.,
2011). Absolute read counts for selected viral taxa were exported from
MEGAN and imported into R, data were normalized, and richness and diversity
were calculated.
De Novo Contig Assembly
Contigs were assembled using the IDBA_UD assembler (v 1.1.0) using mini-
mum and maximum kmer lengths of 20 and 120, respectively (Peng et al.,
2012). All contigs larger than 1,000 nucleotides were compared to a viral
genome reference sequence database consisting of 5,500 viral genomes
available in NCBI as of July 7, 2014, using dc_megablast.
Bacterial 16S rRNA Analysis
16S rRNA Gene Analysis
Stool total nucleic acid was extracted from aliquots of pulverized human stool,
as previously described (Reyes et al., 2013) with minor modifications for lower
throughput processing of human stool (Supplemental Information). Primer
selection and PCR was performed following previously described methods
(Caporaso et al., 2011). The final pooled samples were sequenced on the Illu-
mina MiSeq platform. 16S analysis was done in QIIME (Quantitative Insights
into Microbial Ecology, version 1.8.0) (Caporaso et al., 2010), and OTU relative
abundance, diversity and richness plots were generated in GraphPad Prism
(version 6.0d).
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